93 related articles for article (PubMed ID: 15031524)
1. Development of a questionnaire assessing Buruli ulcer-induced functional limitation.
Stienstra Y; Dijkstra PU; Guédénon A; Johnson RC; Ampadu EO; Mensah T; Klutse EY; Etuaful S; Deepak S; Van Der Graaf WT; Van Der Werf TS
Am J Trop Med Hyg; 2004 Mar; 70(3):318-22. PubMed ID: 15031524
[TBL] [Abstract][Full Text] [Related]
2. Reliability and validity of the Buruli ulcer functional limitation score questionnaire.
Stienstra Y; Dijkstra PU; Van Wezel MJ; Van Roest MH; Beets M; Zijlstra I; Johnson RC; Ampadu EO; Gbovi J; Zinsou C; Etuaful S; Klutse EY; Van der Graaf WT; Van der Werf TS
Am J Trop Med Hyg; 2005 Apr; 72(4):449-52. PubMed ID: 15827284
[TBL] [Abstract][Full Text] [Related]
3. Buruli ulcer: the third most common mycobacterial infection.
Weir E
CMAJ; 2002 Jun; 166(13):1691. PubMed ID: 12126327
[No Abstract] [Full Text] [Related]
4. Risk factors for Buruli ulcer disease (Mycobacterium ulcerans Infection): results from a case-control study in Ghana.
Raghunathan PL; Whitney EA; Asamoa K; Stienstra Y; Taylor TH; Amofah GK; Ofori-Adjei D; Dobos K; Guarner J; Martin S; Pathak S; Klutse E; Etuaful S; van der Graaf WT; van der Werf TS; King CH; Tappero JW; Ashford DA
Clin Infect Dis; 2005 May; 40(10):1445-53. PubMed ID: 15844067
[TBL] [Abstract][Full Text] [Related]
5. Systemic suppression of interferon-gamma responses in Buruli ulcer patients resolves after surgical excision of the lesions caused by the extracellular pathogen Mycobacterium ulcerans.
Yeboah-Manu D; Peduzzi E; Mensah-Quainoo E; Asante-Poku A; Ofori-Adjei D; Pluschke G; Daubenberger CA
J Leukoc Biol; 2006 Jun; 79(6):1150-6. PubMed ID: 16531561
[TBL] [Abstract][Full Text] [Related]
6. The development of a short questionnaire for screening of activity limitation and safety awareness (SALSA) in clients affected by leprosy or diabetes.
; Ebenso J; Fuzikawa P; Melchior H; Wexler R; Piefer A; Min CS; Rajkumar P; Anderson A; Benbow C; Lehman L; Nicholls P; Saunderson P; Velema JP
Disabil Rehabil; 2007 May; 29(9):689-700. PubMed ID: 17453991
[TBL] [Abstract][Full Text] [Related]
7. Assessment of functional limitations caused by Mycobacterium ulcerans infection: towards a Buruli ulcer functional limitation score.
Ellen DE; Stienstra Y; Teelken MA; Dijkstra PU; van der Graaf WT; van der Werf TS
Trop Med Int Health; 2003 Jan; 8(1):90-6. PubMed ID: 12535257
[TBL] [Abstract][Full Text] [Related]
8. Buruli ulcer (Mycobacterium ulcerans infection).
Walsh DS; Portaels F; Meyers WM
Trans R Soc Trop Med Hyg; 2008 Oct; 102(10):969-78. PubMed ID: 18657836
[TBL] [Abstract][Full Text] [Related]
9. [Relapses after surgical treatment of Buruli ulcer in Africa].
Kibadi AK
Bull Soc Pathol Exot; 2006 Oct; 99(4):230-5. PubMed ID: 17111968
[TBL] [Abstract][Full Text] [Related]
10. High rates of apoptosis in human Mycobacterium ulcerans culture-positive buruli ulcer skin lesions.
Walsh DS; Meyers WM; Portaels F; Lane JE; Mongkolsirichaikul D; Hussem K; Gosi P; Myint KS
Am J Trop Med Hyg; 2005 Aug; 73(2):410-5. PubMed ID: 16103613
[TBL] [Abstract][Full Text] [Related]
11. [Distribution of Mycobacterium ulcerans (Buruli ulcer) in the district of Lalo in Benin].
Johnson RC; Sopoh GE; Boko M; Zinsou C; Gbovi J; Makoutode M; Portaels F
Trop Med Int Health; 2005 Sep; 10(9):863-71. PubMed ID: 16135193
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility to Buruli ulcer is associated with the SLC11A1 (NRAMP1) D543N polymorphism.
Stienstra Y; van der Werf TS; Oosterom E; Nolte IM; van der Graaf WT; Etuaful S; Raghunathan PL; Whitney EA; Ampadu EO; Asamoa K; Klutse EY; te Meerman GJ; Tappero JW; Ashford DA; van der Steege G
Genes Immun; 2006 Apr; 7(3):185-9. PubMed ID: 16395392
[TBL] [Abstract][Full Text] [Related]
13. Distribution of Buruli ulcer lesions over body surface area in a large case series in Ghana: uncovering clues for mode of transmission.
Hospers IC; Wiersma IC; Dijkstra PU; Stienstra Y; Etuaful S; Ampadu EO; van der Graaf WT; van der Werf TS
Trans R Soc Trop Med Hyg; 2005 Mar; 99(3):196-201. PubMed ID: 15653121
[TBL] [Abstract][Full Text] [Related]
14. [Traditional treatment for Buruli ulcer in Benin].
Johnson RC; Makoutode M; Hougnihin R; Guedenon A; Ifebe D; Boko M; Portaels F
Med Trop (Mars); 2004; 64(2):145-50. PubMed ID: 15460142
[TBL] [Abstract][Full Text] [Related]
15. Community-based study on knowledge, attitude and practice on the mode of transmission, prevention and treatment of the Buruli ulcer in Ga West District, Ghana.
Renzaho AM; Woods PV; Ackumey MM; Harvey SK; Kotin J
Trop Med Int Health; 2007 Mar; 12(3):445-58. PubMed ID: 17313516
[TBL] [Abstract][Full Text] [Related]
16. Phenolic glycolipid-1 (PGL-1) in Buruli ulcer lesions. First demonstration by immuno-histochemistry.
Mwanatambwe M; Yajima M; Etuaful S; Fukunishi Y; Suzuki K; Asiedu K; Yamada N; Asanao G
Int J Lepr Other Mycobact Dis; 2002 Sep; 70(3):201-5. PubMed ID: 12483968
[TBL] [Abstract][Full Text] [Related]
17. [Buruli ulcer in Togo: a hospital study].
James K; Attipou KK; James YE; Blakime M; Tignokpa N; Abete B
Sante; 2003; 13(1):43-7. PubMed ID: 12925323
[TBL] [Abstract][Full Text] [Related]
18. BCG vaccine effectiveness against Buruli ulcer: a case-control study in Benin.
Nackers F; Dramaix M; Johnson RC; Zinsou C; Robert A; DE Biurrun Bakedano E; Glynn JR; Portaels F; Tonglet R
Am J Trop Med Hyg; 2006 Oct; 75(4):768-74. PubMed ID: 17038709
[TBL] [Abstract][Full Text] [Related]
19. Buruli ulcer and schistosomiasis: no association found.
Stienstra Y; van der Werf TS; van der Graaf WT; Secor WE; Kihlstrom SL; Dobos KM; Asamoa K; Quarshi E; Etuaful SN; Klutse EY; King CH
Am J Trop Med Hyg; 2004 Sep; 71(3):318-21. PubMed ID: 15381813
[TBL] [Abstract][Full Text] [Related]
20. Prospects for vaccine development against Buruli disease.
Huygen K
Expert Rev Vaccines; 2003 Aug; 2(4):561-9. PubMed ID: 14711340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
